Characteristics | EBV infection | p value | |
---|---|---|---|
Positive | Negative | ||
Sex | 0.001 | ||
Male | 46 | 238 | |
Female | 7 | 129 | |
Age (years) | 0.421 | ||
≤ 60 | 31 | 193 | |
> 60 | 22 | 174 | |
Location | 0.599 | ||
Proximal | 14 | 109 | |
Distal | 39 | 255 | |
Tumor size | 0.799 | ||
≤ 5 cm | 29 | 209 | |
> 5 cm | 21 | 140 | |
Differentiation | 0.146 | ||
Well | 6 | 72 | |
Poor | 47 | 295 | |
WHO classification | 0.190 | ||
Well differentiated adenocarcinoma | 6 | 72 | |
Poorly differentiated adenocarcinoma | 46 | 271 | |
Mucinous adenocarcinoma | 0 | 12 | |
Signet ring cell carcinoma | 1 | 12 | |
Tumor invasion depth | 0.045 | ||
T1–T2 | 18 | 79 | |
T3–T4 | 35 | 288 | |
Lymph node metastasis | 0.099 | ||
N0 | 22 | 111 | |
N+ | 31 | 256 | |
Distant metastasis | 0.124 | ||
M0 | 46 | 299 | |
M1 | 5 | 68 | |
TNM stage | 0.001 | ||
I-II | 30 | 121 | |
III-IV | 22 | 245 | |
MSI status | 0.275 | ||
MSS | 10 | 41 | |
MSI-H | 0 | 5 | |
HER2 status | 0.928 | ||
Negative | 9 | 64 | |
Positive | 3 | 20 | |
AFP | 0.322 | ||
Normal | 39 | 262 | |
High | 2 | 6 | |
CA19-9 | 0.247 | ||
Normal | 36 | 215 | |
High | 5 | 53 | |
CA125 | 1.000 | ||
Normal | 26 | 242 | |
High | 4 | 37 | |
CEA | 0.039 | ||
Normal | 47 | 221 | |
High | 2 | 39 |